The Truth Behind Illegal e-cigarette Sales in the UK

Jan.15.2025
The Truth Behind Illegal e-cigarette Sales in the UK
Recent tests on e-cigarette samples in the UK reveal presence of illegal substances, sparking concerns over public safety.

According to a report by Clearing the Air on January 14th, a researcher from ITV News in the UK recently contacted several labs in the country to request testing of e-cigarette samples to detect the presence of synthetic cannabis compounds (Spice). In their email, they specifically stated that this was in preparation for a report on the illegal sale of e-cigarettes and e-cigarette liquid in the UK. The email mentioned a desire to sample and test e-cigarettes and their e-liquids.


Although "Spice" is classified as an illegal substance in the UK, a recent investigation by the BBC found that a significant amount of illegal e-cigarettes contain the substance.


According to a study conducted by the University of Bath for the BBC, synthetic cannabinoids such as "Spice" have different severe effects than tetrahydrocannabinol (THC) and are associated with around half of prison deaths. The study also found that e-cigarettes containing "Spice" are being sold as cannabis e-cigarettes in British schools and are very common. All of these products are currently illegal and sold by drug dealers.


At this time, the Tobacco and e-cigarette Act is being debated in Parliament, which could give the UK government the power to ban flavors in legal e-cigarettes, but it does not cover e-cigarettes containing "Spice." An industry insider, in an interview with Clearing the Air, expressed concern that such reports may be used to scare legislators into supporting crackdowns on legal products, rather than helping to prevent drug dealers from selling already illegal products.


In 2019, American media reported that e-cigarettes were causing young people to develop acute respiratory illnesses, suggesting a link to legal nicotine e-cigarettes. Despite later findings that these cases were actually caused by illegal cannabis e-cigarettes containing vitamin E, prohibitionists continue to use this as an argument for banning legal e-cigarette products.


John Dunne, General Secretary of the UK Vaping Industry Association (UKVIA), warned that...


Consumers can confidently purchase compliant nicotine e-cigarettes from any reputable e-cigarette supplier, as these products are designed to help them transition from traditional cigarettes. The media has been circulating alarmist reports such as "confiscated e-cigarettes from schools contain zombie flavoring," leading people to mistakenly believe that the nicotine e-cigarette industry is responsible for this new trend.


Unless the regulated e-cigarette market (which provides products that are at least 95% less harmful than traditional cigarettes to adult smokers) is clearly distinguished from the illegal products supplied unofficially, people may remain wary of all e-cigarettes and smoking rates could potentially increase again.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion
U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion
An opinion article published by Stars and Stripes argued that the Pentagon’s January nicotine clinical guidelines overemphasize abstinence, fail to reflect the reality that about 30% of active-duty personnel use nicotine, and do not address nicotine pouches as potential harm-reduction products.
Industry Insight
Jun.08
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
British American Tobacco (BAT) CEO Tadeu Marroco said the U.S. unauthorized vape market is worth about £7 billion, or US$9.43 billion. Following a shift in FDA enforcement policy, BAT plans to launch flavored Vuse products in the third quarter and an updated Velo pouch in August or September.
Jun.15
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
As cigarette volumes continue to decline, U.S. convenience-store operators are reconfiguring backbar space to accommodate modern oral nicotine products such as nicotine pouches. Industry data show nicotine pouches have become one of the fastest-growing nicotine categories while generating higher margins for retailers.
Jun.12
Reuters: India Seeks to Dismiss Adani Nicotine Pouch Challenge as Mumbai Airport Dispute Moves to Court
Reuters: India Seeks to Dismiss Adani Nicotine Pouch Challenge as Mumbai Airport Dispute Moves to Court
Reuters reported on July 13, 2026, that India is seeking to dismiss Adani Airports’ legal challenge over nicotine pouch sales at Mumbai International Airport’s duty-free shops. Adani denies wrongdoing and argues that existing drug and cosmetics regulations do not apply to duty-free sales or nicotine pouches.
Innovation
Jul.14 by 2Firsts Perspectives
South Korea Rejects 16 Trillion Won Tax-Evasion Claim Over Chinese Synthetic Nicotine
South Korea Rejects 16 Trillion Won Tax-Evasion Claim Over Chinese Synthetic Nicotine
The South Korean government rejected allegations that Chinese synthetic-nicotine e-liquids were linked to about 16 trillion won in tobacco tax evasion, saying China does not ban synthetic nicotine exports and the estimate is difficult to verify, while acknowledging that pre-law synthetic-nicotine inventory is effectively difficult to tax.
Market
Jun.25
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Vapesourcing has listed RELX Creator Pro 15K as “Coming Soon” with U.S. warehouse shipping options; while the page does not show that RELX has entered the U.S. market through official channels or that the product has received FDA authorization, the listing suggests that Chinese brand-led ENDS products are becoming a new point of observation as the U.S. market reassesses regulatory risk following the FDA’s updated enforcement-priority policy.
Industry Insight
Jun.11